RDHL - Why Is Gastrointestinal Disease Focused-RedHill Biopharma Stock Higher Over 100% Today? | Benzinga
The FDA has granted five years' market exclusivity for RedHill Biopharma Ltd's (NASDAQ: RDHL) Talicia under the Generating Antibiotic Incentives Now Act Qualified Infectious Disease Product designation, as recommended by the FDA Exclusivity Board.
Talicia is a fixed-dose, all-in-one oral capsule combination of two ...